Development of CD46 targeted alpha theranostics in prostate cancer using <sup>134</sup>Ce/<sup>225</sup>Ac-Macropa-PEG<sub>4</sub>-YS5Kondapa Naidu Bobba, Robert R. Flavell|Theranostics|2024Cited by 27